BTG1変異により超競争力のあるB細胞が発症し始めます

Coraline Mlynarczyk¹, Matt Teater¹, Juhee Pae²

¹Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

Science (New York, N.Y.)

|January 19, 2023

まとめ

BTG1の変異により,B細胞はスーパーコンペティターになり,攻撃的なリンパ腫になる. 細胞の競争における進化的トレードオフを強調しています

科学分野:

免疫学
細胞生物学
進化生物学

背景:

多細胞生物は細胞の協力に依存しています
適応性のある免疫系特に生殖中心のB細胞は生存信号の激しい競争を示します
B細胞の競争の調節を理解することは免疫機能と病気にとって極めて重要です

研究の目的:

抗体親和性の成熟過程におけるB細胞適性を調節するBTG1の役割を調査する.
BTG1変異がB細胞の競争に及ぼす分子メカニズムを特定する.
リンパ腫の発生とB細胞の競合障害の関係を理解する.

主な方法:

ヒトのリンパ腫を分析する
新しいマウスモデルの開発
MYCタンパク質誘導運動の調査

主要な成果:

BTG1の変異は重要な免疫ゲートキーパーメカニズムを破壊します
B細胞は"スーパーコンペティター"になり普通の細胞を上回ります
変化したMYCタンパク質誘導運動は,この競争力の向上を裏付けている.
このプロセスは,悪質な臨床結果と関連した,攻撃的で侵襲的なリンパ腫をもたらします.

結論:

BTG1は,免疫反応中のB細胞競争の重要なレギュラーである.
このゲートキーパーメカニズムの障害はリンパ腫の形成を促す可能性があります
免疫駆動の細胞選択と単細胞型の競争の間に進化的トレードオフがあります

さらに関連する動画

12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.5K

10:19

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

1.3K

関連する概念動画

01:33

Cancer-Critical Genes I: Proto-oncogenes

9.1K

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

9.1K

02:23

Abnormal Proliferation

4.6K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

4.6K

01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.6K

02:07

Tumor Progression

6.4K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

6.4K

02:38

Mitogens and the Cell Cycle

6.6K

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

6.6K

02:57

Targeted Cancer Therapies

7.8K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

7.8K

関連する実験動画

BTG1変異により 超競争力のあるB細胞が 発症し始めます